Hrt Financial LP Vanda Pharmaceuticals Inc. Transaction History

Hrt Financial LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.47 - $4.61 $108,486 - $144,127	-31,264 Reduced 50.49%	30,658 $126,000
Q4 2023 Feb 09, 2024	SELL	$3.38 - $4.58 $749,961 - $1.02 Million	-221,882 Reduced 78.18%	61,922 $261,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $1.21 Million - $1.86 Million	283,804 New	283,804 $1.23 Million
Q4 2022 Feb 10, 2023	SELL	$6.87 - $10.96 $523,205 - $834,691	-76,158 Reduced 58.68%	53,627 $396,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $676,772 - $843,097	71,692 Added 123.41%	129,785 $1.28 Million
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $540,845 - $687,821	58,093 New	58,093 $633,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $265,038 - $404,647	-24,450 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $383,620 - $516,873	24,450 New	24,450 $383,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $269,714 - $373,735	-17,571 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $198,810 - $272,209	-12,655 Reduced 41.87%	17,571 $377,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $405,632 - $612,983	30,226 New	30,226 $453,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $110,195 - $155,762	-11,279 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$9.32 - $12.02 $158,467 - $204,376	-17,003 Reduced 60.12%	11,279 $108,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $273,204 - $339,949	28,282 New	28,282 $323,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $113,805 - $254,923	-15,174 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $187,854 - $265,089	15,174 New	15,174 $249,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $286M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.